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The continued and aggressive marketing of breastmilk substitutes 
(BMSs) is a considerable impediment to improving breastfeeding. In 
this ‘In Practice’ article we, as academics, practitioners and child health 
advocates, describe contraventions of the regulations that protect 
breastfeeding in South Africa (SA) and argue that bold, proactive 
leadership to eliminate conflict of interest in respect of the BMS 
industry is urgently required, together with far greater investments in 
proven interventions to promote and support breastfeeding.
The 2016 Lancet Breastfeeding Series estimated that improved 
breastfeeding practices could prevent 72% of hospital admissions for 
diarrhoea and 57% for respiratory infections in low- and middle-
income countries, and could have averted 823 000 deaths in the 
75 Countdown countries in 2015.[1] Yet despite clear evidence of 
the benefits of exclusive and continued breastfeeding for children, 
women and society, far too few children in SA are breastfed. There is 
some urgency to improve breastfeeding rates in view of the profound 
life-course effects of breastfeeding on human health and all the 
Sustainable Development Goals.[2]
In an effort to protect breastfeeding and respond to growing 
evidence of aggressive and inappropriate marketing strategies of 
BMS companies,[3,4] the 34th World Health Assembly in 1981 adopted 
Resolution WHA34.22, which included the International Code of 
Marketing of Breast-milk Substitutes (‘the Code’) as a ‘minimum 
requirement’ to be adopted ‘in its entirety’ (118 nations voted in 
favour, and only the USA voted against). In 1982 Peru became the 
first country to adopt the Code as national legislation. Globally, 136 
out of 194 countries have Code-related legislation, yet contraventions 
and violations persist in the face of weak monitoring and enforcement 
mechanisms.[5]
In 2012, SA legislated the Code through the Regulations Relating 
to Foodstuffs for Infants and Young Children (R991)[6] in terms of 
section 15(1) of the Foodstuffs, Cosmetics and Disinfectants Act, 
Act 54 of 1972,[7] following the Tshwane Declaration of Support for 
Breastfeeding.[8] R991 aims to protect and promote breastfeeding 
by regulating the inappropriate marketing of BMSs to ‘remove 
commercial pressures from the infant feeding arena’, ‘avoid creating 
any conflicts of interest or perverse incentives for individual health 
professionals’ and ‘ensure that financial support for professionals 
working in infant and young child health does not create conflicts 
of interest’.
History of breastfeeding in SA
SA has a complex policy history of protection and promotion of 
breastfeeding. In the early 2000s, the prevention of mother-to-child 
HIV transmission programme recommended replacement feeding 
for infants of women living with HIV and provided free infant 
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formula at public sector health facilities.[9] A decade-long impasse 
in any public messaging in support of breastfeeding began, owing to 
fears of HIV transmission. With accumulating evidence from SA and 
other countries of the harmful effects of reduced breastfeeding rates 
on infant morbidity and mortality,[10-12] and several revisions of World 
Health Organization (WHO) guidance, SA changed its policies in 
2011, adopting breastfeeding as the preferred feeding choice, and in 
2012 ceased providing free infant formula while scaling up access to 
lifelong triple antiretroviral treatment.[8]
Yet despite these policy initiatives to promote exclusive breastfeeding 
for the first 6 months in line with WHO guidelines, only 24% of SA’s 
infants are still exclusively breastfed at 4 - 5 months of age,[13] and 
the current rate of increase will fall short of the Global Nutrition 
Target of 50% exclusive breastfeeding in a country by 2025.[14,15] This 
situation almost certainly contributes to SA’s high under-5 mortality 
rate, compared with other upper- to middle-income countries, of 
42 per 1 000 live births, and persistently high levels of stunting.[13] 
Greater multidimensional efforts in communities, health facilities 
and workplaces are therefore needed to promote, support and protect 
breastfeeding in the SA setting, particularly given concerns about the 
expansion of formula milk markets in the global South.[15]
SA has seen a steady growth in infant formula sales over the past 
15 years, from a retail value of ZAR1 billion in 2004 to ZAR4.2 billion 
in 2018 (a 33.3% per capita increase) and a forecast of over 
ZAR6 billion in 2023.[16] Formula is expensive, and unaffordable for 
the majority of SA families. Depending on the brand, the formula 
alone costs an estimated ZAR375 - 561 a month, with potentially 
devastating implications for SA infants, 37% of whose families live 
below the food poverty line (households where the per capita income 
is <ZAR531 a month).[17] Consequently, many families opt for mixed 
feeding and/or dilute the formula to make it stretch further. While 
inadequate nutrition compromises infant health, keeping bottles 
clean is equally challenging, since 1 in 3 SA infants live in households 
that do not have drinking water on site.[13,18]
It is therefore not surprising that gastroenteritis (9%) and lower 
respiratory tract infections (17%) continue to be leading causes of 
under-5 mortality.[19] Furthermore, the most recent Child Healthcare 
Problem Identification Programme data show that 31% of children who 
died in hospital in 2015 had severe or acute malnutrition.[20]
BMS industry contraventions of SA 
regulations to protect breastfeeding
The National Minister of Health signed R991 into law in 2012 for full 
implementation within 36 months. These regulations restrict how 
infant formula can be advertised and labelled, as well as stipulating 
under which circumstances industry is allowed to contribute 
sponsorship for paediatric/nutrition conferences. While R991 allows 
the BMS industry to contribute to a pooled fund for a conference 
or scientific meeting, direct sponsorship of individual delegates or 
speakers is prohibited and R991 explicitly ‘excludes any promotion 
of designated products’ to health professionals, restricts industry 
involvement to scientific and technical material, and prohibits the 
industry from making any ‘health, medicinal or nutrition claims’. 
The National Department of Health (NDoH) has also produced 
guidelines for industry and healthcare personnel relating to R991.[21]
Experience at the annual University of Cape Town Paediatric 
Refresher Course illustrates the extent of the problem. Between 
2016 and 2018, persistent contraventions of the regulations were 
evident, including claims of health benefits, e.g. specific BMS 
brands to overcome ‘Excessive Crying & Intestinal Gas’ and for 
‘Treatment of Diarrhoea’ and ‘Hungry & Sleepless Infants’ (Fig. 1), 
and a BMS product launch of formula milk containing human milk 
oligosaccharides claiming to be ‘Inspired by nature’s perfection’ 
(Fig.  1) – all of this despite very clear instructions to sponsors to 
comply with the regulations. Similar experiences have been reported 
at other universities.
In 2016, North-West University’s School of Pharmacy hosted a 
symposium at which a BMS company sponsored a ‘baby nutrition’ 
workshop. This contravention of R991 was reported to the NDoH, 
and the session was subsequently cancelled by the organisers following 
receipt of a letter outlining the R991contraventions from the Deputy 
Director-General: HIV/AIDS, TB and Maternal, Child and Women’s 
Health. In July 2019, at the combined South African Thoracic 
Society, Allergy Society of South Africa and Chest Wall International 
Group conference in Pretoria, a BMS company-sponsored breakfast 
symposium on human milk oligosaccharides (Fig. 1) was cancelled 
on the morning by the symposium organisers after concerns were 
raised with the conference organisers and the NDoH regarding 
compliance with R991.
The BMS industry web of influence extends beyond marketing 
and promotion at health professional conferences, and includes a 
conscious intent to cultivate relationships with key thought leaders 
in nutrition and child health and to ‘retain and reward’ those 
who have high peer credibility and are positively disposed to the 
company brand. In 2012, a BMS company hired a consultancy 
firm to undertake a strategic stakeholder mapping exercise. The 
report targeted a number of thought leaders in nutrition and child 
health for engagement (Fig. 2).[22] BMS industry sponsorship of 
universities to host nutrition symposia is an example of targeting 
of health professionals, such as the 14th Continuing Nutrition 
Education Symposium at the University of Pretoria (https://www.
nestlenutrition-institute.org/country/za/) in September 2019 and 
similar examples from East Africa (https://www.nestlenutrition-
institute.org/country/za/news/article/2019/04/25/expansion-of-the-
the-first-1-000-days-nurses-academy-by-nestl%C3%A9-nutrition-
institute-africa-east-africa).
The SA website of a multinational BMS company[23] (Fig. 1) 
currently contains incorrect information about the risks of HIV 
transmission through breastfeeding and the recommendations 
regarding infant feeding and HIV. The website recommends that 
women living with HIV should formula feed for 6 months and 
incorrectly states the risk of HIV transmission through breastfeeding 
as 10% (it is currently ~1% at 6 months with maternal antiretroviral 
therapy).[24] This information blatantly contradicts the current SA 
infant and young child feeding policy, which recommends 6 months 
of exclusive breastfeeding for all and continued breastfeeding up to 
2 years and beyond, irrespective of HIV status.[25]
The above are not isolated cases, but rather part of a global 
phenomenon, with a series of recent reports[5] documenting 
‘consistent, repeated, systematic violations’ by the BMS industry.
Conflict of interest: Understanding 
the potential risks of industry funding
It is important to recognise that conflicts of interest exist within 
the individual or organisation – where, for example, funding from 
a BMS company has the potential to undermine health workers’ 
fiduciary duty to protect and promote child health. While we 
may think that researchers are objective and immune to these 
conflicts, a Cochrane review[26] reported that despite academics’ 
best intentions, conflicts of interest lead researchers to ‘favour 
corporations either consciously or unconsciously’. This favouring 
does not necessarily imply collusion or corruption, but it becomes 
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‘difficult to distinguish subtle, unconscious bias from deliberately 
concealed impropriety’.
In 2014, the International Society of Social Paediatrics and Child 
Health adopted a position statement calling for ‘the end of all 
sponsorship of paediatric educational meetings by the Baby Feeding 
Industry’ and drew attention to the potential dangers arising from 
various types of industry sponsorship.[27] For example, industry 
sponsorship and/or branding of a child health- or nutrition-related 
conference creates the impression that an academic department or 
society publicly endorses formula feeding, while support for salaries, 
equipment and/or research means that a department will be indebted 
to the formula industry – tending to stifle any expression of doubt 
about the latter’s products or practices.
With regard to paediatric and nutrition research, while there 
is indeed a place for evidence relating to the development of 
specialised formula milks, there are concerns about the influence of 
industry: a 2018 BMJ article raised concern about how ‘Extensive 
links between the formula industry and the research, guidelines, 
medical education, and public awareness efforts around cow’s 
milk protein allergy … have raised the question of industry driven 
overdiagnosis.’[28] Between 2006 and 2016 in the UK, specialist 
formula prescriptions increased by 500% and National Health 
Service spending on these products increased by 700% from 
GBP8.1 million to GBP60 million.
It is important to recognise that these conflicts of interest extend 
beyond sponsorship of conferences to influence on national policy 
formulation and academia, where far more substantial offers 
of financial support may undermine the integrity of research 
and teaching programmes. Fig. 1 provides an example of an 
advertisement for a research study comparing three types of infant 
formula.
Implementing strategies to prevent 
and mitigate conflicts of interest
R991 makes provision for sanctions when its regulations are 
contravened. The penalties applicable to the contravention of any of 
the regulations are found in section 18 of the Foodstuffs, Cosmetics 
and Disinfectants Act.[7] It prescribes that ‘[a]ny person convicted of 
an offence under this Act shall be liable (a) on a first conviction, to 
a fine or to imprisonment for a period not exceeding six months or 
to both a fine and such imprisonment’. Yet in SA there is minimal 
monitoring, reporting or enforcement. There is an urgent need for 
clearly defined monitoring, reporting and enforcement mechanisms 
that have some traction to deter contraventions. It is also unclear 
who, besides the BMS company, is accountable for the contravention, 
and the role of event organisers and organising committees, in respect 
of conferences and meetings, requires clarity.
So how do health professionals go about addressing conflicts 
of interest? A first step towards creating greater awareness and 
understanding of conflicts of interest is to include teaching on ethics 
and practice in undergraduate and in-service health professional 
training. By not introducing these concepts into undergraduate 
education, health professionals enter practice at risk of judgement 
errors when confronted with BMS industry influence in clinical or 
academic contexts. R991 applies to both the public and the private 
sectors, and education and awareness of the regulations and conflicts 
of interest are therefore needed in both sectors, particularly with the 
forthcoming public-private contracting proposed in SA’s National 
Health Insurance.
From an ethical standpoint, health professionals must declare 
any funding, contractual relationship or in-kind support from BMS 
companies in any public statement, publications or conference 
presentations. However, the optimal approach would be to adopt a 
clear and unequivocal position and refuse all industry funding of 
child health- or nutrition-related work if health professionals are to 
maintain professional integrity and safeguard the health of the most 
vulnerable women and children.
In February 2019, after an outcry against BMS sponsorship of its 
conference in Cairo, the UK Royal College of Paediatrics and Child 
Health issued a statement announcing that it would no longer accept 
any funding from the formula milk industry. It would continue 
to ‘engage and work in partnership’ with formula milk companies 
with regard to specialist formula milks, but without accepting any 
funding.[29] The College had received ~GBP40 000 a year from BMS 
companies through event sponsorship and advertising.
In March 2019, the BMJ (and its sister publications) stated their 
intent no longer to run infant formula advertisements: ‘After decades 
of advertising breastmilk substitutes to readers of the BMJ, we have 
decided it is time to stop.’[30] We call on SA health and nutrition 
journals to adopt similar advertising policies.
Fig. 2. BMS company stakeholder mapping. Names of individuals and the company concerned have been concealed. (BMS = breastmilk substitutes.)
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At its recent executive meeting, the South African Paediatric 
Association agreed in principle not to accept any further funding 
from BMS companies. Bold moves such as this are what are needed to 
send a clear message to an industry that is adept at finding loopholes 
and infiltrating audiences where they know they will have the greatest 
impact.
Now is an appropriate time for the child health and nutrition 
communities to pause and reconsider any relationships with the 
baby food industry, including funding for research, conferences and 
other educational initiatives, particularly when infant feeding and 
allergy are involved. We therefore call on academic departments 
and professional associations to demonstrate their commitment 
to protect breastfeeding from the commercial influence of BMS 
companies in southern Africa, and to adopt clear position statements 
that signal their intention to: (i) refuse any further offers of BMS 
industry sponsorship for academic conferences, research or teaching 
programmes; (ii) disclose current sources of BMS company funding 
of research and teaching programmes, and require upfront disclosure 
of funding sources in any publications or presentations arising 
therefrom; (iii) take active steps to minimise the impact of any 
existing conflicts of interest; (iv) educate health professionals, staff 
and students about the benefits of breastfeeding and measures 
to address the conflicts of interest associated with BMS funding; 
(v)  intensify efforts to promote, support and protect breastfeeding; 
and (vi) monitor implementation of R991 and the Code and report 
any contraventions to the NDoH.
Dedication. We dedicate this ‘In Practice’ article to Emeritus Professor 
David Sanders, who died following the acceptance of the article. David, 
a paediatrician and child health advocate, dedicated his life to improving 
the health and nutrition of children, especially the most vulnerable, 
through his research, writing, teaching and activism. A key focus of his 
work was the political economy of health and the role of transnational 
food companies in driving unhealthy dietary choices, including feeding 
of infants. The struggle for health will continue through the innumerable 
lives that he influenced across the globe.
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